Loading...

2,281 posters, 63 videos, 56 audios, 43 topics, 18 sessions, 6,174 authors, 2,323 institutions

ePostersLive by SciGen Technologies S.A. All rights reserved.

RCOG World Congress 2025

June 23 - 25, 2025 | ExCeL London, UK

EP.1907

REVIEW OF POSTNATAL MATERNAL READMISSIONS IN A DISTRICT GENERAL HOSPITAL (UNITED KINGDOM)

Part of Topic

Quality improvement

Review Of Postnatal Maternal Readmissions in a District General Hospital (United Kingdom)

Dr. Simran Seth, Dr. Sana Bhatia, Dr. Gagbodawaththe Perera, Miss Vandna Verma


Introduction:

Maternal readmission after childbirth is considered an indicator of maternal morbidity and quality of care provided by a hospital1 . This adversely impacts the mother - infant bonding but also increases the cost of maternity care. According to National and Maternity and Perinatal Audit Clinical report 2022, postnatal readmission rates were higher following a caesarean birth compared with a vaginal birth in both England (4.3% vs 2.9%) and Wales (4.7% vs 3.3%).

Objective:

We aim to study all cases of postnatal maternal readmission over a specified period to understand common indications and identify changes in practice that may decrease the chances of readmission, especially among those having a caesarean birth.

To ascertain the number of women readmitted to hospital within 30 days of delivery

To identify the reasons for readmission to hospital

To describe the outcomes of readmission - investigations, medication, management and length of hospital stay

To Identify any risk factors for readmissions

Identify preventive measures which could have been put in place at the time of discharge

Identify changes in practice that may decrease the chance of readmission.


Design and Methodology:

Retrospective study conducted as an audit in a district general hospital in the UK. 

The audit covered twelve months between September 2023-September 2024, including all women readmitted within 30 days of delivery.

Data included age, BMI, parity, antenatal risk factors(preeclampsia/pregnancy induced hypertension (PET/PIH), gestational diabetes, smoking), and comorbidities (essential hypertension, diabetes mellitus, asthma and hypothyroidism), referral source, reasons for readmission, investigations, and management. Data also covered delivery details such as intrapartum complications, mode of delivery(spontaneous, assisted, caesarean-section), estimated blood loss and postoperative complications.

Data checked if intraoperative antibiotics were given or if PICO dressings were used for patients with BMI ≥ 35. In cases of intrapartum/postpartum pyrexia, data reflects whether IV antibiotics were administered and if patients were discharged on oral antibiotics. Lastly, data tracks antenatal and intrapartum antihypertensives, postpartum continuation and discharge on antihypertensives.


 

Copyright © 2015-2026, ePostersLive® SciGen is a registered trademark of SciGen Technologies S.A. Patent pending.

This website and third-party tools we use rely on cookies for the best user experience. By selecting "I agree", you agree to cookie usage as described in our Privacy Policy.